Iovance Biotherapeutics Inc reports results for the quarter ended in March - Earnings Summary

Iovance Biotherapeutics

09/05/2024 23:04

* Iovance Biotherapeutics Inc  IOVA.OQ  reported a quarterly
adjusted loss of 42 cents​​ per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of -50 cents.  The mean expectation of
thirteen analysts for the quarter was for a loss of 42 cents per
share. Wall Street expected results to range from -50 cents
to -32 cents per share.
    * Revenue was $715.00 thousand​; analysts expected $2.08
million. 
    * Iovance Biotherapeutics Inc's reported EPS for the quarter
was a
loss of 42 cents​.
    * The company reported a quarterly loss of $112.98 million.
    * Iovance Biotherapeutics Inc shares had fallen by 9.6% this
quarter and gained 64.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 11.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Iovance
Biotherapeutics Inc is $25.50 
This summary was machine generated from LSEG data May 9 at 10:04
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.42          -0.42          Met
 Dec. 31 2023      -0.43          -0.45          Missed
 Sep. 30 2023      -0.45          -0.46          Missed
 Jun. 30 2023      -0.80          -0.47          Beat